Previous 10 | Next 10 |
2023-05-24 13:33:04 ET In its preliminary annual 2023 Russell indexes reconstitution, a total of 164 companies will be added and 319 deleted from the Russell microcap index. Following notable healthcare companies will be added and deleted from Russell microcap index: Notable additio...
2023-05-17 12:37:04 ET Summary Today, we revisit genetic testing concern Natera, Inc., as the shares are up more than 30% so far in 2023. The company continues to deliver solid revenue growth even as its cash burn rate remains a concern. Which way do Natera, Inc. shares go fro...
2023-05-15 16:59:32 ET Invitae ( NYSE: NVTA ) said it will appeal a verdict in a patent case in a federal court in Delaware that found in favor of Natera ( NTRA ). Invitae ( NVTA ) has been ordered to pay $19.35M for infringing some Natera ( NTRA ) patents. The...
Invitae to Appeal Trial Verdict PR Newswire SAN FRANCISCO , May 15, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it intends to appeal the verdict delivered by a jury at the United States Distr...
2023-05-10 11:15:04 ET Summary Invitae reports limited Q1 beats as expectations drop. Guidance maintained, but cash burn still high. Another capital raise may be needed for future growth. After the bell on Tuesday, we received first quarter results from genetics ...
2023-05-09 20:30:22 ET Image source: The Motley Fool. Invitae (NYSE: NVTA) Q1 2023 Earnings Call May 09, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: Invitae (NVTA) Q1 2023 Earnings Call Transcript
2023-05-09 18:25:22 ET Invitae Corporation (NVTA) Q1 2023 Earnings Conference Call May 09, 2023 04:30 PM ET Company Participants Hoki Luk - Investor Relations Ken Knight - President & Chief Executive Officer Robert Daber - Chief Scientific Officer Roxi We...
2023-05-09 16:12:23 ET Invitae press release ( NYSE: NVTA ): Q1 Non-GAAP EPS of -$0.37 beats by $0.03 . Revenue of $117.36M (-5.1% Y/Y) beats by $0.79M . Non-GAAP gross profit was $56.2 million in the quarter, compared with $45.2 million in the first quarter of...
Invitae Reports First Quarter 2023 Financial Results PR Newswire – Reported revenue of $117.4 million , a 5% year-over-year decrease due to exited businesses and geographies; pro forma year-over-year revenue growth was ~10% – – Continued improve...
2023-05-08 10:34:40 ET This will surely be another wild week for investors. Regional bank stocks are surging to start the Monday session as cooler heads prevail after last week’s insanity. But then you’ve got upcoming catalysts like Wednesday’s May CPI inflation data, m...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...